Image

Entre Herman@s: Promoting Health Among Latino MSM

Entre Herman@s: Promoting Health Among Latino MSM

Non Recruiting
18-39 years
All
Phase N/A

Powered by AI

Overview

This is a randomized controlled trial with an attention placebo control group. The goal of this study is to decrease HIV incidence in Latino men who have sex with men by engaging their siblings in PrEP-use promotion. In the intervention arm, siblings will be trained to engage their gay brother in PrEP conversations. In the control arm, siblings will be trained to engage their gay brother in conversations about vaccines to prevent COVID, Hepatitis A/B, or MPOX.

Eligibility

Inclusion Criteria: Latino Men Who Have Sex with Men

  1. self-identify as Latino
  2. identify as male
  3. be <40 years old
  4. report HIV-negative status
  5. be willing to talk about MSM healthcare issues with a sibling
  6. either (a) have never used PrEP or (b) stopped using PrEP at least 90 days ago
  7. missing most recent COVID vaccine
  8. missing Hepatitis (A or B) vaccines
  9. missing Mpox vaccine
  10. meet CDC's PrEP eligibility criteria (be HIV-negative; any male sex partner in the past six months; not in a monogamous partnership with a recently tested, HIV-negative man; and at least one of the following: any anal sex without condoms in past 6 months, any sexually-transmitted infection (STI) diagnosed or reported in past 6 months, or is in an ongoing sexual relationship with an HIV-positive male partner).

Exclusion Criteria: Latino Men Who Have Sex with Men

  1. are unable to provide consent or
  2. they do not meet any of the criteria above

Inclusion Criteria: Siblings

  1. at least 18 years old
  2. report a close relationship his/her LMSM brother <40 years old
  3. be willing to talk about MSM healthcare issues with his/her LMSM brother

Exclusion Criteria: Siblings

  1. are unable to provide consent or
  2. they do not meet any of the criteria above

Study details
    HIV Infections

NCT05805306

Charles Drew University of Medicine and Science

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.